Effect of early antiretroviral therapy on the risk of AIDS/death in HIV-infected infants.

Goetghebuer, Tessa;Haelterman, Edwige;Le Chenadec, Jerome;Dollfus, Catherine;Van der Linden, Dimitri;et.al.
(2009) AIDS —

Files

125178.pdf
  • Restricted Access
  • Adobe PDF
  • 179.73 KB

Details

Authors
  • Goetghebuer, Tessa
    Author
  • Haelterman, Edwige
    Author
  • Le Chenadec, Jerome
    Author
  • Dollfus, Catherine
    Author
  • Van der Linden, DimitriUCLouvain
    Author
Show more
Abstract
In HIV-1 vertically infected infants, starting antiretroviral therapy before the age of 3 months is associated with a significant reduction in progression to AIDS and death.
Affiliations

Citations

Goetghebuer, T., Haelterman, E., Le Chenadec, J., Dollfus, C., Gibb, D., Judd, A., Green, H., Galli, L., Ramos, J. T., Giaquinto, C., Warszawski, J., Levy, J., & Van der Linden, D. (2009). Effect of early antiretroviral therapy on the risk of AIDS/death in HIV-infected infants. AIDS. https://doi.org/10.1097/QAD.0b013e328326ca37